Related Experiment Videos
[Human bone marrow mesenchymal stem cells express multiple hematopoietic growth factors]
Guang-Rong Zhu1, Xiao-Yu Zhou, Hua Lu
1Department of Hematology, the First Affiliated Hospital of Nanjing Medical University, Nanjing 210029, China.
Zhongguo Shi Yan Xue Ye Xue Za Zhi
|May 15, 2003
Summary
Human bone marrow mesenchymal stem cells (BM-MSCs) express key hematopoietic growth factors, supporting their role in blood cell formation. Hydrocortisone treatment enhances the expression of certain factors, suggesting therapeutic potential.
Area of Science:
- Stem Cell Biology
- Hematopoiesis Research
- Molecular Biology
Background:
- Human bone marrow mesenchymal stem cells (BM-MSCs) are crucial for maintaining hematopoietic stem cell niches.
- Understanding BM-MSC expression of hematopoietic growth factors is vital for regenerative medicine and leukemia/lymphoma research.
Purpose of the Study:
- To investigate the biological role of human BM-MSCs in hematopoiesis.
- To analyze the expression of multiple hematopoietic growth factors by BM-MSCs from healthy donors and patients with hematological malignancies.
Main Methods:
- Reverse Transcription Polymerase Chain Reaction (RT-PCR) was employed to detect mRNA expression of specific cytokines.
- BM-MSCs were cultured and treated with or without hydrocortisone (HC) to assess its effect on cytokine expression.
Main Results:
- Cultured BM-MSCs expressed mRNA for stem cell factor (SCF), Flt3-ligand, thrombopoietin (TPO), leukemia inhibitory factor (LIF), interleukin-6 (IL-6), and IL-11.
- BM-MSCs from leukemia and lymphoma patients exhibited a similar cytokine expression pattern.
- Hydrocortisone (HC) induced the expression of granulocyte colony-stimulating factor (G-CSF) but not granulocyte-macrophage colony-stimulating factor (GM-CSF).
Conclusions:
- Normal and patient BM-MSCs possess the potential to promote hematopoiesis due to their expression of multiple hematopoietic cytokines.
- Hydrocortisone (HC) can induce the expression of hematopoietic growth factors in BM-MSCs, highlighting a potential therapeutic strategy.